Adiponectin-deficient mice exhibit insulin resistance [38], and adiponectin replacement in humans was reported to be a promising method to prevent and/or treat obesity and type 2 diabetes [39]. Here, ADIPOQ is linked to obesity due to melanocortin 4 receptor deficiency.